Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Prostatic neoplasms malignant
ADR ID BADD_A03561
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.25      Reproductive neoplasms male malignant and unspecified
16.25.01      Prostatic neoplasms malignant
Description Not Available
MedDRA Code 10036908
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02174Testosterone undecanoate-
BADD_D02192Thalidomide0.000241%
BADD_D02236Tofacitinib--
BADD_D02237Tofacitinib citrate--
BADD_D02241Tolcapone--
BADD_D02297Triptorelin--
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000926%
BADD_D02348Verapamil0.000099%
BADD_D02392Zoledronic acid--
BADD_D02441Rasagiline0.001624%
BADD_D02445Solifenacin0.000608%
BADD_D02470Nintedanib--
BADD_D02487Baricitinib0.000482%
BADD_D02490Apalutamide0.005673%
BADD_D02539Calcium0.000587%
BADD_D02548Darolutamide0.010010%
BADD_D02567Lutetium lu-177 vipivotide tetraxetan-
BADD_D02586Radium ra-223 dichloride-
BADD_D02587Relugolix0.002503%
The 3th Page    First    Pre   3    Total 3 Pages